The Philadelphia Inquirer writes on the reported $2.2 billion Johnson & Johnson Risperdal settlement, the $2.3 billion Pfizer Geodon penalty, the $3 billion GlaxoSmithKline Avandia settlement, and the fact that “no human being, apparently, is going to be held responsible for substantial criminal activity by a corporation.”
